{"schema_version":"secwatch.filing_event.v1","accession":"0001667011-23-000028","form_type":"8-K","ticker":"AIP","cik":"0001667011","company_name":"Arteris, Inc.","filed_at":"2023-11-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.999017+00:00","generated_at":"2026-06-08T15:55:04.510244+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Arteris Q3 revenue $13.3M (+5% YoY); ACV+royalties $57.3M (+8%); guides Q4 rev $11.3-12.3M","bullets":["ACV+TTM royalties $57.3M, up 8% YoY; net loss $8.2M ($0.23/share); non-GAAP net loss $4.2M ($0.12/share).","Revenue $13.3M (+5% YoY); operating loss $8.5M (63.7% of revenue); non-GAAP operating loss $4.5M.","Q4 guidance: revenue $11.3-12.3M; ACV+TTM royalties $52-56M; non-GAAP op loss 56.1%-76.1% of revenue.","RPO of $62.5M; 22 design starts in Q3 (12 AI-enabled); secured top-10 global fabless semiconductor customer.","FlexNoC 5 closed 9 deals since Q2 2023 release; NeuReality, AlChip, Fraunhofer partnerships announced."],"urls":{"canonical":"https://secwatch.observer/filing/0001667011-23-000028","json":"https://secwatch.observer/filing/0001667011-23-000028.json","markdown":"https://secwatch.observer/filing/0001667011-23-000028.md","text":"https://secwatch.observer/filing/0001667011-23-000028.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1667011/000166701123000028/0001667011-23-000028-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1667011/000166701123000028/aip-20231107.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T15:55:04.510244+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3ecf347e7d0546783645b25e39024d9d1d7570be","claim":"Arteris, Inc. reported the third quarter ended September 30, 2023 results: revenue $13.3 million, net income $8.2 million or $0.23 per share, EPS $0.23 per share. Guidance initiated.","evidence_excerpt":"Third Quarter 2023 Financial Highlights: • Annual Contract Value (ACV) and Trailing-twelve-month (TTM) variable royalties of $57.3 million, up 8% year-over-year • Revenue of $13.3 million, up 5% year-over-year • Remaining performance obligation (RPO) of $62.5 million • Operating loss of $8.5 million or 63.7% of revenue • Non-GAAP operating loss of $4.5 million or","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1667011/000166701123000028/0001667011-23-000028-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the third quarter ended September 30, 2023"},{"label":"Revenue","value":"$13.3 million"},{"label":"Net income","value":"$8.2 million or $0.23 per share"},{"label":"EPS","value":"$0.23 per share"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}